Table V.
Graft lesions, events, and interventions*
Group |
||||
---|---|---|---|---|
Characteristic | Overall (%) | Statin | Control | P |
Graft disease burden | ||||
No significant disease | 64 (34) | 33 | 31 | .72 |
Subcritical stenosis | 23 (12) | 12 | 11 | .80 |
Critical stenosis | 38 (20) | 24 | 14 | .06 |
Occlusion | 21 (11) | 7 | 14 | .11 |
Unknown | 43 (23) | 18 | 25 | .24 |
Clinical events | ||||
Overall | 49 (100) | 22 | 27 | .43 |
Elective revision | 28 (57) | 15 | 13 | .66 |
Graft occlusion | 21 (43) | 7 | 14 | .11 |
Interventions | ||||
Overall | 42 (100) | 20 | 22 | .76 |
Thrombolysis/Thrombectomy | 4 (10) | 1 | 3 | .32 |
Angioplasty | 10 (25) | 7 | 3 | .19 |
Interposition/Jump graft | 13 (31) | 6 | 7 | .79 |
Combination/Multiple | 3 (7) | 2 | 1 | .55 |
Amputation | 3 (7) | 2 | 1 | .55 |
New graft constructed | 9 (21) | 2 | 7 | .09 |
Time to intervention (days) | ||||
Mean | 230 ± 228 | 225 ± 203 | 234 ± 251 | .90 |
Median | 176 | 182 | 152 |
Data shown as either coded raw data (n) with percent or summary data (mean ± SD).